Oncology Information System (OIS) Market, Global Outlook and Forecast 2023-2028

Report ID: 1570415 | Published Date: Jan 2025 | No. of Page: 60 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Oncology Information Management Systems (OIMS) are an important part of radiation oncology.
This report contains market size and forecasts of Oncology Information System (OIS) in Global, including the following market information:
Global Oncology Information System (OIS) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Oncology Information System (OIS) market was valued at 2107.4 million in 2021 and is projected to reach US$ 3141 million by 2028, at a CAGR of 5.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Patient Information System Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oncology Information System (OIS) include Accuray Incorporated, Bogardus Medical Systems, Cerner Corporation, CureMD Corporation, Elekta, Flatiron Health, McKesson, RaySearch Laboratories and Varian Medical Systems and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oncology Information System (OIS) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncology Information System (OIS) Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Oncology Information System (OIS) Market Segment Percentages, by Type, 2021 (%)
Patient Information System
Treatment Planning System
Global Oncology Information System (OIS) Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Oncology Information System (OIS) Market Segment Percentages, by Application, 2021 (%)
Radiation Oncology
Medical Oncology
Surgical Oncology
Global Oncology Information System (OIS) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Oncology Information System (OIS) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oncology Information System (OIS) revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Oncology Information System (OIS) revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Accuray Incorporated
Bogardus Medical Systems
Cerner Corporation
CureMD Corporation
Elekta
Flatiron Health
McKesson
RaySearch Laboratories
Varian Medical Systems
Bizmatics

Frequently Asked Questions
Oncology Information System Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oncology Information System Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oncology Information System Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports